Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
Menu
NET Nurse
Donate
What are NETs?
Patients & Carers
Healthcare Professionals
Get Involved
NET Nurse
Donate
What are NETs?
  • What are Neuroendocrine Cancers?
  • What are Pheos & Paras?
  • NET Symptoms
  • Causes
  • Treatments
  • Grades
National Action Plan
Patients & Carers
  • Patient & Carer Support
  • Patient Resources
  • Optimal Care Pathway
  • NET Nurse
  • Patient Stories
  • Share your Story
  • Australian NET Specialists
  • Clinical Trials
  • Living with NETS
National Action Plan
Healthcare Professionals
  • Optimal Care Pathway
  • Professional Learning
  • Patient Referral
  • Clinical Trials
  • NET Symptoms
  • Australian NET Specialists
  • Request an In-Service
  • PLANET Registry
  • Order Booklets & Resources
National Action Plan
Get Involved
  • Advocate for Us
  • Share your Story
  • Donate
  • Fundraise
  • Events
  • In Memoriam
  • Corporate Partners
  • Gifts & Wills
  • Volunteer
National-Action-Plan-1.png
NET Nurse
Donate

Home » Research » CONTROL NETS Randomised Controlled Clinical Trial

CONTROL NETS Randomised Controlled Clinical Trial

  • December 4, 2013
In the very competitive research environment, the development and submission for National Health and Medical Research (NHMRC) grants is an onerous, stressful and demanding task. 

During the 2013 round of NHMRC Project Grant Applications, despite positive reviewer comments such as"…this is an excellent project and worthy of support. The scientific quality id high…" and a ranking in the 2nd quartile of Category 5 applications, the CONTROL NETs (APP1069017) grant application was ultimately unsuccessful. Given that only 17% if projects were funded, our group of dedicated clinical researchers were not alone.

Capecitabine On Temozolamide Radionuclide Therapy Octreotate Lutetium177 for Gastroenteropancreatic Neuroendocrine Tumours (CONTROL NETs) is a vitally important randomised control trial and the results have the potential to change practice and strongly influence the clinical management of NET patients worldwide.

The Unicorn Foundation remains committed to this project and our patients needs are being represented by Dr John Leyden on the research committee. 

For all our supporters and donors, this project is still a funding priority for The Unicorn Foundation and we strongly encourage you to give generously so that we can raise $200,000 or more to assist in the running of this trial. If you would like to fundraise for this study, please contact Simone Leyden at simone.leyden@neuroendocrine.org.au

Share this post

Subscribe to our eNews

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Recent posts

Have your say on #EndGenderBias in Australia’s healthcare system

September 19, 2023
Workshop attendees

NECA/Ipsen Workshop: Improving NET Awareness & Time to Diagnosis

August 24, 2023
NET Forum Perth

Perth NET Forum Recap

August 22, 2023
South Australia Cancer Nursing Society of Australia Groups Education Dinner

South Australia Cancer Nursing Society of Australia Groups Education Dinner

August 18, 2023
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousANSTO Gets $5 Million Funding from Federal Government
NextPeter MacCallum Publishes LuTate Study ResultsNext

Related Posts

The Australian Cancer Plan

Shaping the future of cancer control together   We are pleased to send you this update on the Australian Cancer Plan, the first national 10-year

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness

Read full report

Peter MacCallum Cancer Centre – Recruiting NET health professionals for International Delphi survey

Recruiting NET health professionals for International Delphi survey Development of a neuroendocrine tumour (NET) nutrition-risk screening tool to identify patients requiring nutrition intervention and education

Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms

Read full report

View All

Make a difference

How much do you wish to donate?
$50
$100
$250
$500
$1000
Other

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • What Are Neuroendocrine Cancers?​
  • What Are Pheos & Paras?
  • National Patient Awareness
  • What Are Neuroendocrine Cancers?​
  • What Are Pheos & Paras?
  • National Patient Awareness

Patients & Carers

  • Patient & Carer Support
  • Patient Resources
  • Optimal Care Pathway
  • NET Nurse
  • National Action Plan
  • Patient Stories
  • Share your story
  • Australian NET Specialists
  • Clinical Trials
  • Living with NETS
  • Patient & Carer Support
  • Patient Resources
  • Optimal Care Pathway
  • NET Nurse
  • National Action Plan
  • Patient Stories
  • Share your story
  • Australian NET Specialists
  • Clinical Trials
  • Living with NETS

Healthcare Professionals

  • Optimal Care Pathway
  • Professional Learning
  • Patient Referral
  • Clinical Trials
  • NET Symptoms
  • Australian NET Specialists
  • Request an In-Service
  • PLANET Registry
  • Order Booklets & Resources
  • Optimal Care Pathway
  • Professional Learning
  • Patient Referral
  • Clinical Trials
  • NET Symptoms
  • Australian NET Specialists
  • Request an In-Service
  • PLANET Registry
  • Order Booklets & Resources

Get Involved

  • Advocate for us
  • Share your story
  • Donate
  • Fundraise
  • Events
  • In Memoriam
  • Corporate Partners
  • Gifts & Wills
  • Volunteer
  • Advocate for us
  • Share your story
  • Donate
  • Fundraise
  • Events
  • In Memoriam
  • Corporate Partners
  • Gifts & Wills
  • Volunteer
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2023 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin

What's on?

How to identify a neuroendocrine cancer when it’s not part of the typical line up. A RACGP & ACN CPD accredited course.

Share this course with your healthcare professional so they can enrol in this free online course and learn more about how to diagnose and treat NETs in general practice.

Learn More